U.S. Reverses Measles Elimination Status Amid Surge in Cases and Low Vaccination Rates

The Pan American Health Organization has formally revoked the U.S.'s measles elimination status due to a significant outbreak in 2026, with over 5,400 cases reported—more than double the previous year's total. Declining vaccination rates, particularly among kindergarteners at just 92.4% for the MMR vaccine, have undermined herd immunity, with some states reporting rates as low as 75%. Public health officials attribute the resurgence to persistent vaccine skepticism and the influence of U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a known critic of vaccines despite no scientific evidence linking the MMR vaccine to autism.
In November 2026, the Pan American Health Organization (PAHO) formally revoked the United States’ measles elimination status due to a surge in cases exceeding 5,400—more than double the 2025 total of 2,289—and eight associated deaths. This marks a reversal of a public health milestone achieved in 2000, when the U.S. was declared free of endemic measles transmission. The resurgence is directly linked to declining vaccination rates, particularly among kindergarteners, who reached only 92.4% MMR coverage in 2026—below the 95% threshold needed for herd immunity. Some states reported rates as low as 75%, creating vulnerable communities where outbreaks can spread rapidly. The outbreak has been exacerbated by persistent vaccine skepticism, with public health experts pointing to U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., a known critic of vaccines despite no scientific basis for linking MMR to autism. His leadership has drawn criticism from researchers like Yale’s Gregg Gonsalves, who accused him of undermining disease prevention efforts. In response, PAHO requires the U.S. to submit a corrective action plan detailing enhanced surveillance, rapid outbreak response, and targeted vaccination campaigns in low-coverage areas. The U.S. must also demonstrate sustained progress over time before it can regain its status, similar to Canada’s path after losing elimination status in 2025.
The loss of measles elimination status could erode public trust in national health institutions and amplify vaccine hesitancy, particularly in communities already skeptical of government health messaging. This may lead to broader resistance against other immunizations, affecting long-term disease control efforts. The situation mirrors the 2019 measles outbreak in the U.S., which also stemmed from low vaccination rates and led to widespread media scrutiny and policy reviews. However, unlike then, this time the federal leadership’s role is under direct public and expert criticism, potentially influencing future political accountability around public health. Adjacent institutions like state health departments may face increased pressure to act independently, possibly leading to fragmented responses across regions. The broader impact could include strain on healthcare systems during outbreaks and rising costs for outbreak containment. Comparable to the 2018–2019 measles resurgence in Europe, this event may prompt international collaboration or new regional guidelines. What remains uncertain is whether federal leadership will shift course, how quickly states can implement effective vaccination drives, and whether public perception of HHS will change—especially as PAHO’s requirements for reinstatement are stringent and long-term.